[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100385172":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":19,"responsibleParty":38,"collaborators":10,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":10,"eligibilityCriteria":46,"healthyVolunteers":42,"sex":47,"minAge":48,"maxAge":10,"enrollmentInfo":49,"targetDuration":52,"studyType":53,"phases":10,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":22,"whyStopped":10,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Niguarda Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"cardiogenic shock patients",null,"All-comers cardiogenic shock patients Admitted to the Intensive Coronary Care Units",[13],{"name":14,"role":15,"phone":16,"phoneExt":17,"email":18},"Alice Sacco, MD","CONTACT","+39026444","2643","alice.saccoi@ospedaleniguarda.it",[20],{"facility":21,"status":22,"city":23,"state":10,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"ASST GOM Niguarda","RECRUITING","Milan","20125","Italy","IT",{"type":28,"coordinates":29},"Point",[30,31],12.59836,42.78235,{"lat":31,"lon":30},[34],{"name":14,"role":15,"phone":35,"phoneExt":36,"email":37},"+026444","2308","alice.sacco@ospedaleniguarda.it",{"type":39,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100385172","altshock-2-registry-100385172",false,"NCT04295252","Altshock-2 REGISTRY","Cardiogenic Shock: a Prospective National Registry to Get Insights in Patients' Profile, Management and Outcome","All consecutive CS patients hospitalized in the above reported centres between January 2020 and December 2030.\n\nCardiogenic shock is defined as:\n\n1. Systolic blood pressure (SBP) \\\u003C90 mmHg or mean arterial pressure (MAP) \\\u003C60 mmHg, after an appropriate fluid challenge if there is no sign of overt fluid overload, OR need of vasoactive agents to maintain SBP \\> 90 mmHg or MAP \\> 60 mmHg, OR need of MCS;\n2. At least one of the following criteria\u002Fsigns of overt hypoperfusion: mixed venous oxygen saturation \\\u003C60%; arterial lactates \\> 2 mmol\u002FL; oliguria \\\u003C 0.5 ml\u002FKg\u002Fh for at least 6 hours.","ALL","18 Years",{"count":50,"type":51},3000,"ESTIMATED","1 Day","OBSERVATIONAL","The study will provide data on profile, management, outcome, and evolution over time of cardiogenic shock patients admitted to the Intensive Coronary Care Units",[56],"Cardiogenic Shock",[58],"cardiogenic shock","2026-05-13",{"date":61,"type":62},"2026-05-14","ACTUAL",{"date":64,"type":62},"2020-07-01",{"date":66,"type":51},"2031-12-31",{"name":5,"class":6},1]